Production of Tetanus Antitoxin by Patients with Hepatic Cirrhosis

THE noteworthy effectiveness of active immunization against tetanus by means of tetanus toxoid has not obviated the use of equine antitoxin, since there is still a large segment of the population that has not been actively immunized. In addition, certain conditions in the presumably actively immunized person, such as uncertainty about immunization history, severe injuries about the head or neck, delay of twenty-four hours in treatment and the omission of a booster dose of toxoid for several years, are usually considered as indications for employing passive as well as active immunization when injury is sustained. Lastly, the rare occurrence of . . .